DJIA 15,354.40 121.18 0.80%
NASDAQ 3,498.97 33.73 0.97%
S&P 500 1,667.47 17.00 1.03%

7.98 -0.02 (-0.25%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ARNA $7.98 -0.25%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $8.05
Previous Close $8.00
Daily Range $7.94 - $8.06
52-Week Range $5.44 - $13.50
Market Cap $1.7B
P/E Ratio -22.22
Dividend (Yield) $0.00 (0.0%)
Volume 2,394,611
Average Daily Volume 5,418,843
Current FY EPS -$0.12

Sector

Healthcare

Industry

Drugs

Arena Pharmaceuticals, Inc. (ARNA) Description

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. Website: http://www.arenapharm.com/

News & Commentary

25 Belt-Busting Obesity Facts

A list of fascinating statistics about America's biggest health problem.

Vivus Taps Into More Cash

Arena Outlines Belviq Launch And Goals

Weight Loss Isn't Just for Looking Good Anymore

Medical benefits are helping obesity drugs get coverage. Will the government help?

Vivus - Mild Drama Continues

Vivus Starting To Gain The Advantage Over Arena

Arena, Vivus, And Off-Label Prescriptions

Deal Discussions Distract From Disappointing Obesity Drug Sales

Making sense of Vivus' first quarter results for investors.

Short Interest in Vertex Rises, in Celgene Falls

Belviq's Sales Will Disappoint: Demographics Matter

See More ARNA News...

ARNA's Top Competitors

ARNA $7.98 (-0.25%)
Current stock: ARNA
AMGN $105.63 (0.63%)
Current stock: AMGN
GILD $56.30 (2.44%)
Current stock: GILD
BIIB $226.85 (-0.50%)
Current stock: BIIB